Status:
TERMINATED
Interest in Evaluating Primary Hemostasis in Patients With Veno-venous Extracorporeal Membrane Oxygenation (ECMO)
Lead Sponsor:
Rennes University Hospital
Conditions:
Patients With ECMO
Eligibility:
All Genders
18+ years
Brief Summary
The aim of the study is a better understanding of hemorrhagic events causes in patients with ECMO, prevent them and decrease the number of transfusion.
Detailed Description
The most frequent complication during ECMO is hemorrhage especially as a curative anticoagulant treatment is necessary. The primary hemostasis is also affected with a von Willebrand disease and thromb...
Eligibility Criteria
Inclusion
- Patient older than 18 years old
- Patient with ECMO
- Patient hospitalized in an intensive care unit at the University Hospital of Rennes
Exclusion
- Known history for constitutional pathology of the primary haemostasis
- Platelets \< 100000 / mm3 or hematocrit \< 28 % between H+12 and H+24
Key Trial Info
Start Date :
February 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2016
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT03248596
Start Date
February 1 2016
End Date
July 1 2016
Last Update
November 21 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Rennes
Rennes, France, 35033